Icon

Illumina Inc Stock Analysis and Price Target COMMON STOCK | Diagnostics & Research | NSD

stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 196.65

+2.14 (+1.10)%

USD 30.75B

1.43M

USD 252.17(+28.23%)

USD 238.00 (+21.03%)

Icon

ILMN

Illumina Inc (USD)
COMMON STOCK | NSD
USD 196.65
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 30.75B

USD 238.00 (+21.03%)

USD 196.65

Illumina Inc Stock Forecast

Show ratings and price targets of :
USD 252.17
(+28.23%)

Based on the Illumina Inc stock forecast from 17 analysts, the average analyst target price for Illumina Inc is USD 252.17 over the next 12 months. Illumina Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Illumina Inc is Slightly Bearish, which is based on 4 positive signals and 6 negative signals. At the last closing, Illumina Inc’s stock price was USD 196.65. Illumina Inc’s stock price has changed by -7.52% over the past week, -2.80% over the past month and -17.88% over the last year.

No recent analyst target price found for Illumina Inc
No recent average analyst rating found for Illumina Inc

Company Overview

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables...Read More

https://www.illumina.com

5200 Illumina Way, San Diego, CA, United States, 92122

11,500

December

USD

USA

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Illumina Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc -1.45 (-0.31%) USD38.92B 55.23 37.65

ETFs Containing ILMN

Symbol Name ILMN's Weight Expense Ratio Price(Change) Market Cap
EKG
First Trust Nasdaq Lux Di.. 7.68 % 0.65 % +0.11 (+0.68%) USD0.84M

Frequently Asked Questions About ILMN Stock

Based on ratings from 17 analysts Illumina Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 9 buy, 1 sell and 6 hold ratings.

Unfortunately we do not have enough data on ILMN's stock to indicate if its a good dividend stock.

Based on targets from 17 analysts, the average taret price for ILMN is USD 252.17 over the next 12 months. The maximum analyst target price is USD 334 while the minimum anlayst target price is USD 150.

ILMN stock's Price/Earning ratio is 91.22. Our analysis grades ILMN stock's Price / Earning ratio at F. This means that ILMN stock's Price/Earning ratio is above 87% of the stocks in the Diagnostics & Research sector in the NSD exchange. Based on this ILMN may be a overvalued for its sector.

The last closing price of ILMN's stock was USD 196.65.

The most recent market capitalization for ILMN is USD 30.75B.

Based on targets from 17 analysts, the average taret price for ILMN is projected at USD 252.17 over the next 12 months. This means that ILMN's stock price may go up by +28.23% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...